- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Fabian Lang on the Importance of Patient Involvement in CML Treatment Decisions
In a disease such as chronic myeloid leukemia (CML), shared treatment decision-making between providers and patients is key, said Fabian Lang, MD, of Goethe University Hospital in Frankfurt, Germany.
In a disease such as chronic myeloid leukemia (CML), shared treatment decision-making between providers and patients is key, said Fabian Lang, MD, of Goethe University Hospital in Frankfurt, Germany.
Transcript
What are the potential benefits of patient involvement in treatment decision-making for both the patients and health care providers?
Especially in CML, where we're talking about compounds and medications [that] have been taken over several years, an involved and shared decision-making is quite important in order to ensure compliance, and by ensuring compliance, you ensure efficacy. So if you want to treat and conduct your CML therapy properly, you have to make sure that you have an informed consent within this treatment.
What should providers keep in mind when involving patients in CML treatment decision-making, particularly when presenting multiple treatment options to patients?
It's quite difficult, so I think you have to decide beforehand which medication opportunities are there, and then you have to narrow to the most important points. So it's not like saying, "We've got to 5 medications at hand, so just choose one." That's got [to be], "We have this medication with these kinds of advantages, and there are these specific side effects," and that overall comes together to find a shared decision.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
